242 related articles for article (PubMed ID: 27637382)
21. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Ma F; Du H
Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Saeed A; Zaib S; Ashraf S; Iftikhar J; Muddassar M; Zhang KY; Iqbal J
Bioorg Chem; 2015 Dec; 63():58-63. PubMed ID: 26440714
[TBL] [Abstract][Full Text] [Related]
23. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.
Elsinghorst PW; Härtig W; Goldhammer S; Grosche J; Gütschow M
Org Biomol Chem; 2009 Oct; 7(19):3940-6. PubMed ID: 19763296
[TBL] [Abstract][Full Text] [Related]
24. Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease.
Lemes LFN; de Andrade Ramos G; de Oliveira AS; da Silva FMR; de Castro Couto G; da Silva Boni M; Guimarães MJR; Souza INO; Bartolini M; Andrisano V; do Nascimento Nogueira PC; Silveira ER; Brand GD; Soukup O; Korábečný J; Romeiro NC; Castro NG; Bolognesi ML; Romeiro LAS
Eur J Med Chem; 2016 Jan; 108():687-700. PubMed ID: 26735910
[TBL] [Abstract][Full Text] [Related]
25. One-pot synthesis of tetrazole-1,2,5,6-tetrahydronicotinonitriles and cholinesterase inhibition: Probing the plausible reaction mechanism via computational studies.
Hameed A; Zehra ST; Abbas S; Nisa RU; Mahmood T; Ayub K; Al-Rashida M; Bajorath J; Khan KM; Iqbal J
Bioorg Chem; 2016 Apr; 65():38-47. PubMed ID: 26851737
[TBL] [Abstract][Full Text] [Related]
26. 6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
Semenov VE; Zueva IV; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
ChemMedChem; 2015 Nov; 10(11):1863-74. PubMed ID: 26412714
[TBL] [Abstract][Full Text] [Related]
27. Cholinesterase inhibitory activity of chlorophenoxy derivatives-Histamine H3 receptor ligands.
Łażewska D; Jończyk J; Bajda M; Szałaj N; Więckowska A; Panek D; Moore C; Kuder K; Malawska B; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2016 Aug; 26(16):4140-5. PubMed ID: 27445168
[TBL] [Abstract][Full Text] [Related]
28. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
[TBL] [Abstract][Full Text] [Related]
29. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B
Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744
[TBL] [Abstract][Full Text] [Related]
31. Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity.
Bosak A; Knežević A; Gazić Smilović I; Šinko G; Kovarik Z
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):789-797. PubMed ID: 28573890
[TBL] [Abstract][Full Text] [Related]
32. Effects of structural modifications on the metal binding, anti-amyloid activity, and cholinesterase inhibitory activity of chalcones.
Fosso MY; LeVine H; Green KD; Tsodikov OV; Garneau-Tsodikova S
Org Biomol Chem; 2015 Sep; 13(36):9418-26. PubMed ID: 26248214
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
34. Chalcone-based carbamates for Alzheimer's disease treatment.
Rampa A; Montanari S; Pruccoli L; Bartolini M; Falchi F; Feoli A; Cavalli A; Belluti F; Gobbi S; Tarozzi A; Bisi A
Future Med Chem; 2017 May; 9(8):749-764. PubMed ID: 28498775
[TBL] [Abstract][Full Text] [Related]
35. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid.
Geula C; Greenberg BD; Mesulam MM
Brain Res; 1994 May; 644(2):327-30. PubMed ID: 8050043
[TBL] [Abstract][Full Text] [Related]
36. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
[TBL] [Abstract][Full Text] [Related]
37. Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.
Darvesh S; Macdonald IR; Martin E
Bioorg Med Chem Lett; 2013 Jul; 23(13):3822-5. PubMed ID: 23707254
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors.
Kia Y; Osman H; Suresh Kumar R; Basiri A; Murugaiyah V
Bioorg Med Chem Lett; 2014 Apr; 24(7):1815-9. PubMed ID: 24594354
[TBL] [Abstract][Full Text] [Related]
39. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
Saeedi M; Golipoor M; Mahdavi M; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A
Arch Pharm (Weinheim); 2016 Apr; 349(4):293-301. PubMed ID: 26898241
[TBL] [Abstract][Full Text] [Related]
40. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
